Neuralstem, Inc. today reported that Eva Feldman, MD, PhD, principal investigator, presented updated Phase I data from its spinal cord-derived human neural stem cell trial in the treatment of amyotrophic lateral sclerosis at the neuro diabetes special medical symposium in Bucharest, Romania, on Friday.
http://www.drugs.com/clinical_trials/neuralstem-als-trial-principal-investigator-presents-phase-data-15556.html?
http://www.drugs.com/clinical_trials/neuralstem-als-trial-principal-investigator-presents-phase-data-15556.html?
No comments:
Post a Comment